Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report

  • Maremmani A
  • Rovai L
  • Rugani F
  • et al.
N/ACitations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Nowadays, the misuse of benzodiazepines (BZDs) is a cause for a serious concern among pharmacologically inexperienced patients, whether treated or untreated, that could lead to significant complications, including tolerance, dependence, and addiction. We present a case report in which an Italian patient affected by anxiety disorder and treated with BZDs presented a severe case of dependence on BZDs. We treated him according to an agonist substitution approach, switching from the abused BZD to a slow-onset, long-acting, high potency agonist (clonazepam), and looking at the methadone treatment model as paradigm. We decided to use clonazepam for its pharmacokinetic properties. The advantage of choosing a slow-onset, long-lasting BZD for the treatment of our patient was that it led us to a remarkable improvement in the clinical situation, including the cessation of craving, absence of withdrawal symptoms, reduced anxiety, improvements in social functioning, and a better cognition level.

Cite

CITATION STYLE

APA

Maremmani, A. G. I., Rovai, L., Rugani, F., Bacciardi, S., Pacini, M., Dell’Osso, L., & Maremmani, I. (2013). Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report. Case Reports in Psychiatry, 2013, 1–4. https://doi.org/10.1155/2013/367594

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free